Fexofenadine Hydrochloride & Montelukast Tablets – All-Day Allergy & Asthma Protection.
FEXOVON M Tablets: The Dual Composition of Fexofenadine HCL 120 mg & Montelukast Sodium 10 mg film-coated Tablet is a combination of two drugs, namely Montelukast (leukotriene receptor antagonist) and Fexofenadine (antihistamine). Montelukast belongs to the class of leukotriene receptor antagonists that work by blocking the action of chemicals called leukotrienes released from the lungs, causing inflammation (swelling) and increased mucus production in the airways. This reduces inflammation, mucus production, and narrowing in the airways. Fexofenadine belongs to the class of antihistamines (anti-allergic drugs) that work by blocking the action of histamine, a substance responsible for causing allergic reactions. It helps relieve allergy symptoms such as sneezing, a runny nose, watery eyes, itching, swelling, and congestion or stiffness.
Recommended By Specialists:
✅Pulmonologists: It is preferred to treat the disease associated with asthma and allergic rhinitis.
✅General Physicians: It is preferred to treat the disease associated with allergic rhinitis and sinusitis with allergy.
✅Pulmonologists: It is preferred to treat the disease associated with asthma and allergic rhinitis.
Key benefits of Fexofenadine Hydrochloride & Montelukast Tablets – FEXOVON M Tablets:
✅Dual-Action Relief combines two powerful medications to provide comprehensive relief from allergic rhinitis (hay fever) and asthma symptoms, offering a holistic solution for patients with both conditions.
✅Convenient DOSE: Once-Daily Dosage provides continuous relief from allergy and asthma symptoms, simplifying treatment and improving adherence.
✅All-Day Symptom: Control ensures all-day protection, and the combination addresses both the immediate symptoms of allergies and the underlying inflammatory process in asthma, providing comprehensive management for individuals with complex symptoms.
INDICATIONS:
✅Seasonal and Perennial Allergic Rhinitis
✅Chronic Urticaria (Hives)
✅Asthma
✅Exercise-Induced Bronchoconstriction (EIB)